New cellular therapies like CAR-T cells, CAR-NK cells, and CAR-macrophages are in full development. Furthermore, hematopoietic stem cell transplantation is one of the cornerstones of leukemia treatment.
Besides cellular therapies, targeted molecular therapy is an important focus area. Several small molecule inhibitors have emerged or are being developed. These compounds target directly mutations, downstream signaling networks, or cellular processes such as apoptosis, DNA repair, the epigenome or the metabolism of cancer cells.